Matches in SemOpenAlex for { <https://semopenalex.org/work/W2904128847> ?p ?o ?g. }
- W2904128847 endingPage "3064" @default.
- W2904128847 startingPage "3056" @default.
- W2904128847 abstract "Primary immunodeficiency (PID) diseases result from genetic defects of the immune system that increase a patient's susceptibility to infections. The types of infections that occur in patients with PID diseases are dictated largely by the nature of the immunodeficiency, which can be defined by dysfunction of cellular or humoral defenses. An increasing number of PID diseases, including those with both cellular and humoral defects, have antibody deficiency as a major feature, and as a result can benefit from immunoglobulin replacement therapy. In fact, the most common PID diseases worldwide are antibody deficiencies and include common variable immunodeficiency, congenital agammaglobulinemia, hyper‐IgM syndrome, specific antibody deficiency, and Good syndrome. Although immunoglobulin replacement therapy is the cornerstone of treatment for the majority of these conditions, a thorough understanding of the specific infections for which these patients are at increased risk can hasten diagnosis and guide additional therapies. Moreover, the infection trends in some patients with PID disease who have profound defects of cellular immunity, such as autosomal‐dominant hyper‐IgE syndrome (Job/Buckley syndrome) or dedicator of cytokinesis 8 (DOCK8) deficiency, suggest that select patients might benefit from immunoglobulin replacement therapy even if their immunodeficiency is not limited to antibody defects. In this review, we provide an overview of the predisposition to infections seen in PID disease that may benefit from immunoglobulin replacement therapy." @default.
- W2904128847 created "2018-12-22" @default.
- W2904128847 creator A5020324049 @default.
- W2904128847 creator A5030968289 @default.
- W2904128847 creator A5055750176 @default.
- W2904128847 date "2018-12-01" @default.
- W2904128847 modified "2023-09-25" @default.
- W2904128847 title "Humoral immunodeficiencies: conferred risk of infections and benefits of immunoglobulin replacement therapy" @default.
- W2904128847 cites W107772810 @default.
- W2904128847 cites W1588637297 @default.
- W2904128847 cites W1892457185 @default.
- W2904128847 cites W1908021215 @default.
- W2904128847 cites W1966265903 @default.
- W2904128847 cites W1967829819 @default.
- W2904128847 cites W1969471051 @default.
- W2904128847 cites W1971597034 @default.
- W2904128847 cites W1972868972 @default.
- W2904128847 cites W1981355577 @default.
- W2904128847 cites W1986009116 @default.
- W2904128847 cites W1988484579 @default.
- W2904128847 cites W1995928670 @default.
- W2904128847 cites W1996109838 @default.
- W2904128847 cites W2013876082 @default.
- W2904128847 cites W2014373531 @default.
- W2904128847 cites W2021521359 @default.
- W2904128847 cites W2024544474 @default.
- W2904128847 cites W2027008928 @default.
- W2904128847 cites W2027935291 @default.
- W2904128847 cites W2027979845 @default.
- W2904128847 cites W2031402064 @default.
- W2904128847 cites W2034296986 @default.
- W2904128847 cites W2040123224 @default.
- W2904128847 cites W2045462207 @default.
- W2904128847 cites W2045705588 @default.
- W2904128847 cites W2049156141 @default.
- W2904128847 cites W2053567093 @default.
- W2904128847 cites W2055234427 @default.
- W2904128847 cites W2057695882 @default.
- W2904128847 cites W2057877742 @default.
- W2904128847 cites W2061014664 @default.
- W2904128847 cites W2065293336 @default.
- W2904128847 cites W2067372248 @default.
- W2904128847 cites W2069431676 @default.
- W2904128847 cites W2070036391 @default.
- W2904128847 cites W2073959180 @default.
- W2904128847 cites W2076657480 @default.
- W2904128847 cites W2079678184 @default.
- W2904128847 cites W2081793182 @default.
- W2904128847 cites W2083392007 @default.
- W2904128847 cites W2089324774 @default.
- W2904128847 cites W2090377701 @default.
- W2904128847 cites W2094527741 @default.
- W2904128847 cites W2101671673 @default.
- W2904128847 cites W2104459473 @default.
- W2904128847 cites W2125317769 @default.
- W2904128847 cites W2126347405 @default.
- W2904128847 cites W2127403035 @default.
- W2904128847 cites W2128943836 @default.
- W2904128847 cites W2134678353 @default.
- W2904128847 cites W2142127956 @default.
- W2904128847 cites W2150234903 @default.
- W2904128847 cites W2151929844 @default.
- W2904128847 cites W2156156989 @default.
- W2904128847 cites W2158792709 @default.
- W2904128847 cites W2162721157 @default.
- W2904128847 cites W2163945612 @default.
- W2904128847 cites W2193601845 @default.
- W2904128847 cites W220975793 @default.
- W2904128847 cites W2253670074 @default.
- W2904128847 cites W2256178893 @default.
- W2904128847 cites W2294047647 @default.
- W2904128847 cites W2339930775 @default.
- W2904128847 cites W2398944043 @default.
- W2904128847 cites W2408932056 @default.
- W2904128847 cites W2464771733 @default.
- W2904128847 cites W2496969299 @default.
- W2904128847 cites W2519409486 @default.
- W2904128847 cites W2527368952 @default.
- W2904128847 cites W2527945427 @default.
- W2904128847 cites W2536271466 @default.
- W2904128847 cites W2550167636 @default.
- W2904128847 cites W2555668645 @default.
- W2904128847 cites W2567251402 @default.
- W2904128847 cites W2591757899 @default.
- W2904128847 cites W2592164063 @default.
- W2904128847 cites W2607259909 @default.
- W2904128847 cites W2617519810 @default.
- W2904128847 cites W2738615923 @default.
- W2904128847 cites W2752351338 @default.
- W2904128847 cites W2774787224 @default.
- W2904128847 cites W2806637763 @default.
- W2904128847 cites W4319054007 @default.
- W2904128847 cites W2473872168 @default.
- W2904128847 doi "https://doi.org/10.1111/trf.15020" @default.
- W2904128847 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6939302" @default.
- W2904128847 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30536429" @default.
- W2904128847 hasPublicationYear "2018" @default.
- W2904128847 type Work @default.